<DOC>
	<DOC>NCT01194375</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of IDP-107 versus placebo in treating patients with acne vulgaris.</brief_summary>
	<brief_title>A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Presence of acne vulgaris on the face and neck/trunk Presence of inflammatory and noninflammatory lesions on the face Presence of any skin condition on the face that could interfere with clinical evaluations Use of any systemic antibiotics or corticosteroids within 4 weeks prior to the Baseline visit Use of any systemic retinoids, such as isotretinoin, within 3 months prior to the Baseline visit Woman who is pregnant, nursing an infant, or planning a pregnancy during the study period</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>